write news report on - 'covid 19 vaccination started all over India'
Answers
Answer:
India’s COVID vaccination drive is scheduled to start on January 16 with priority given to an estimated three crore healthcare workers and the frontline workers, the Health Ministry said on Saturday.
It added that this will be followed by voluntary vaccination of those above 50 years of age and the under-50 population groups with co-morbidities, numbering around 27 crore.The announcement followed a meeting chaired by Prime Minister Narendra Modi to review the status of the pandemic in the country along with the preparedness of the State/UTs for COVID vaccination.
Emergency Use Authorisation or Accelerated Approval has been granted by the National Regulator for two vaccines — Covishield and Covaxin — which have established safety and immunogenicity, the release said.
According to the Ministry, the Prime Minister was briefed about the preparedness of the Centre in close collaboration with the State and UT governments for roll out of the vaccine.
Coronavirus | I would not take the vaccine without efficacy data: Gagandeep Kang
People’s participation
“The vaccination exercise will use the principles of people’s participation (Jan Bhagidari), experience of elections (booth strategy) and Universal Immunization Program (UIP). There will be no compromise of existing healthcare services, especially national programmes and primary health care. We aim for it to be an orderly and smooth implementation driven by technology,” noted the release.
The Prime Minister was also apprised about the Co-WIN Vaccine Delivery Management System, noted the release.
“The digital platform will provide real time information of vaccine stocks, their storage temperature and individualized tracking of beneficiaries of the COVID-19 vaccine,” said the Ministry.
It added that this platform will assist the program managers across all levels through automated session allocation for pre-registered beneficiaries, their verification and for generating a digital certificate upon successful completion of the vaccine schedule. More than 79 lakh beneficiaries have been already registered on the platform.
As the vaccinators and vaccine administrators comprise a crucial pillar of the vaccination exercise, their training process was detailed at the meeting.
The Health Ministry said 2,360 participants were trained during national level Training of Trainers which comprised State immunisation officers, cold chain officers, IEC officials, development partners etc.
Also more than 61,000 programme managers, two lakh vaccinators and 3.7 lakh other vaccination team members have been trained so far as part of trainings at States, districts and block levels as per Ministry data.
The Prime Minister was also apprised on the three phases of dry runs that have been conducted across the country.
“The third dry run was conducted on Friday across 615 districts covering 4,895 session sites in 33 States/UTs. After the detailed review, it was decided that in view of the forthcoming festivals including Lohri, Makar Sankranti, Pongal, Magh Bihu etc., the COVID-19 vaccination will start following the festivals,” the Ministry noted.
Answer:
India began administration of COVID-19 vaccines on 16 January 2021. As of 29 April 2021, India has administered 152,245,179 doses overall, including first and second does of the currently-approved vaccines.[2][3]
Two vaccines received approval for emergency use in India at the onset of the program, including Covishield (a version of the Oxford–AstraZeneca vaccine manufactured by the Serum Institute of India), and Covaxin (developed by Bharat Biotech). In April 2021, Sputnik V was approved as a third vaccine, with deployment expected to begin by late-May 2021
Background and timeline
A vaccination centre in Delhi.
In September 2020, India's science minister Harsh Vardhan stated that the country planned to approve and begin distribution of a vaccine by the first quarter of 2021.[5] The first recipients were to be 30 million health workers directly dealing with COVID patients.[6]
On 1 January 2021, the Drug Controller General of India (DCGI) approved emergency usage of the Oxford–AstraZeneca vaccine, which was being manufactured by the Serum Institute of India (SII) under the trade name "Covishield".[7][8][9] On 2 January, the DCGI approved Bharat Biotech's Covaxin for emergency use, even though it had not yet completed phase 3 trials.[10][11]
India began its vaccination program began on 16 January 2021, operating 3,006 vaccination centres on the onset.[12] Each vaccination centre will offer either Covishield or Covaxin, but not both. Some states have decided to primarily use Covishield, and keep their Covaxin doses as a “buffer stock”.[13] Since Covaxin has not completed phase-3 trials, those receiving it will need to sign a consent form.[14]
165,714 people were vaccinated on the first day of availability. Difficulties in uploading beneficiary lists at some sites caused delays.[15] In the first three days, 631,417 people were vaccinated. Of these, 0.18% reported side-effects and nine people (0.002%) were admitted to hospitals for observation and treatment.[16][17] Within those first days, there was concerns about low turnout, due to a combination of vaccine safety concerns, technical problems with the software used, and misinformation.[18]
The first phase of the rollout involved health workers and frontline workers including police, paramilitary forces, sanitation workers, and disaster management volunteers.[12] By 1 March, only 14 million healthcare and frontline workers had been vaccinated, falling short of the original goal of 30 million.[19]
The next phase of the vaccine rollout covered all residents over the age of 60, residents between the ages of 45 and 60 with one or more qualifying comorbidities, and any health care or frontline worker that did not receive a dose during phase 1. Online registration began on 1 March via the Aarogya Setu app and a web-based booking system.[20][21][22] From 1 April, eligibility was extended to all residents over the age of 45.[23]